COLGATE PALMOLIVE CO

CL 10-Q · Q2 2025
API behind this page

CL Q2 2025 request

Playground key active
Request URL /api/financials?ticker=CL&year=2025&quarter=2
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q2 2025 Q2 2024 YoY
Revenue 5,110 5,058 +1.0%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 295 273 +8.1%
Oral, Personal and Home Care · Asia Pacific 687 682 +0.7%
Oral, Personal and Home Care · Europe 738 685 +7.7%
Oral, Personal and Home Care · Latin America 1,207 1,267 -4.7%
Oral, Personal and Home Care · North America 1,027 1,037 -1.0%
Oral, Personal and Home Care · Operating Segments 3,954 3,944 +0.3%
Pet Nutrition · Operating Segments 1,157 1,114 +3.9%
Cost of Revenue 2,041 1,992 +2.5%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 117 105 +11.4%
Oral, Personal and Home Care · Asia Pacific 265 260 +1.9%
Oral, Personal and Home Care · Europe 275 258 +6.6%
Oral, Personal and Home Care · Latin America 527 504 +4.6%
Oral, Personal and Home Care · North America 403 396 +1.8%
Pet Nutrition · Operating Segments 462 459 +0.7%
Gross Profit 3,069 3,066 +0.1%
Selling, General & Administrative 1,963 1,939 +1.2%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 110 103 +6.8%
Oral, Personal and Home Care · Asia Pacific 242 232 +4.3%
Oral, Personal and Home Care · Europe 272 251 +8.4%
Oral, Personal and Home Care · Latin America 318 353 -9.9%
Oral, Personal and Home Care · North America 417 426 -2.1%
Pet Nutrition · Operating Segments 430 420 +2.4%
Other Operating Income Expense Net 26 35 -25.7%
Operating Income 1,080 1,092 -1.1%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 65 64 +1.6%
Oral, Personal and Home Care · Asia Pacific 187 195 -4.1%
Oral, Personal and Home Care · Europe 184 169 +8.9%
Oral, Personal and Home Care · Latin America 367 417 -12.0%
Oral, Personal and Home Care · North America 194 213 -8.9%
Oral, Personal and Home Care · Operating Segments 997 1,058 -5.8%
Pet Nutrition · Operating Segments 264 235 +12.3%
Show Consolidation Items breakouts
Corporate Non Segment -181 -201 +10.0%
Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component 23 22 +4.5%
Interest Expense 71 78 -9.0%
Interest Income 21 18 +16.7%
Income Before Taxes 1,007 1,010 -0.3%
Income Tax Expense (Benefit) 234 243 -3.7%
Net Income 773 767 +0.8%
Show Equity Components breakouts
Noncontrolling Interest 30 36 -16.7%
Retained Earnings 743 731 +1.6%
Net Income Loss Attributable To Noncontrolling Interest 30 36 -16.7%
Net Income 743 731 +1.6%
EPS (Basic) 0.92 0.89 +3.4%
EPS (Diluted) 0.91 0.89 +2.2%
Comprehensive Income 936 622 +50.5%
Wtd Avg Shares (Basic) 810.2 819.7 -1.2%
Wtd Avg Shares (Diluted) 813.3 823.7 -1.3%
Net Income Loss Available To Common Stockholders Basic 743 731 +1.6%

Balance Sheet

Balance Sheet
Metric Q2 2025 Q2 2024 YoY
Current Assets
Cash & Cash Equivalents 1,215 1,110 +9.5%
Accounts Receivable 1,773 1,825 -2.8%
Inventory 2,120 1,922 +10.3%
Other Assets Current 888 789 +12.5%
Total Current Assets 5,996 5,646 +6.2%
Non-Current Assets
Property, Plant & Equipment 4,529 4,392 +3.1%
Goodwill 3,696 — —
Deferred Tax Assets 218 214 +1.9%
Other Non-Current Assets 1,127 1,094 +3.0%
Total Assets 17,470 16,480 +6.0%
Other Assets
Property Plant And Equipment Gross 10,665 10,167 +4.9%
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment -6,136 -5,775 -6.3%
Intangible Assets Net Excluding Goodwill 1,904 1,814 +5.0%
Current Liabilities
Short Term Bank Loans And Notes Payable 1,614 509 +217.1%
Accounts Payable 1,790 1,557 +15.0%
Accrued Income Taxes Current 321 399 -19.5%
Other Accrued Liabilities Current 3,050 2,864 +6.5%
Total Current Liabilities 6,775 5,350 +26.6%
Non-Current Liabilities
Long-Term Debt 7,144 8,146 -12.3%
Deferred Tax Liabilities 279 355 -21.4%
Other Non-Current Liabilities 2,220 2,147 +3.4%
Total Liabilities 16,418 15,998 +2.6%
Long-Term Debt (Q) — — —
Show Fair Value By Measurement Basis breakouts
Carrying Reported Amount Fair Value Disclosure 8,758 8,167 +7.2%
Stockholders' Equity
Common Stock 1,466 1,466 0.0%
Additional Paid-In Capital 4,246 4,035 +5.2%
Retained Earnings 26,735 25,486 +4.9%
Accumulated Other Comprehensive Income -3,924 -4,128 +4.9%
Treasury Stock Common Value -27,821 -26,736 -4.1%
Total Stockholders' Equity 702 123 +470.7%
Minority Interest 350 359 -2.5%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1,052 482 +118.3%
Show Equity Components breakouts
Accumulated Other Comprehensive Income -3,924 -4,128 +4.9%
Additional Paid In Capital 4,246 4,035 +5.2%
Common Stock 1,466 1,466 0.0%
Noncontrolling Interest 350 359 -2.5%
Retained Earnings 26,735 25,486 +4.9%
Treasury Stock Common -27,821 -26,736 -4.1%
Total Liabilities & Equity 17,470 16,480 +6.0%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2025 YTD Q2 2024 YoY
Operating Activities
Depreciation & Amortization 299 307 -2.6%
Show Business Segments breakouts
Oral, Personal and Home Care · Africa/Eurasia 4 4 0.0%
Oral, Personal and Home Care · Asia Pacific 40 40 0.0%
Oral, Personal and Home Care · Europe 32 32 0.0%
Oral, Personal and Home Care · Latin America 51 53 -3.8%
Oral, Personal and Home Care · North America 60 63 -4.8%
Oral, Personal and Home Care · Operating Segments 187 192 -2.6%
Pet Nutrition · Operating Segments 63 67 -6.0%
Show Consolidation Items breakouts
Corporate Non Segment 49 48 +2.1%
Litigation Settlement Expense 65 — —
Show Retirement Plan Type breakouts
Pension Plans Defined Benefit · US 50 — —
Restructuring Net Of Cash -13 48 -127.1%
Stock-Based Compensation 55 43 +27.9%
Deferred Income Taxes And Tax Credits -17 -92 +81.5%
Increase Decrease In Receivables -152 -309 +50.8%
Change in Inventory 3 -17 +117.6%
Increase Decrease In Accounts Payable And Accrued Liabilities -248 194 -227.8%
Increase Decrease In Other Operating Capital Net -7 2 -450.0%
Net Cash from Operations 1,484 1,671 -11.2%
Investing Activities
Payments To Acquire Productive Assets -232 -243 +4.5%
Payments To Acquire Marketable Securities -384 -243 -58.0%
Proceeds From Sale And Maturity Of Marketable Securities 350 178 +96.6%
Payments To Acquire Businesses Net Of Cash Acquired -293 — —
Other Investing Activities -1 4 -125.0%
Net Cash from Investing -560 -304 -84.2%
Financing Activities
Proceeds From Repayments Of Short Term Debt -30 736 -104.1%
Repayments Of Other Debt -139 -500 +72.2%
Proceeds From Other Debt 497 2 +24750.0%
Payments Of Ordinary Dividends -880 -867 -1.5%
Share Repurchases -516 -989 +47.8%
Proceeds From Stock Options Exercised 65 455 -85.7%
Proceeds From Payments For Other Financing Activities 136 -43 +416.3%
Net Cash from Financing -867 -1,206 +28.1%
Supplemental
Income Taxes Paid 530 505 +5.0%
Interest Paid 137 161 -14.9%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 62 -17 +464.7%
Net Change in Cash 119 144 -17.4%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,215 1,110 +9.5%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key